Edmond Fleischer
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
-
- Drug Transport and Resistance Mechanisms
Papers in
-
- Histone Deacetylase Inhibitors Research 3
- Cancer therapeutics and mechanisms 3
- Protein Degradation and Inhibitors 2
- Oncology 9
- Drug Transport and Resistance Mechanisms 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- Anette Klinger (18 shared papers)Thomas Efferth (19 shared papers)Sara Abdelfatah (6 shared papers)Brian C. Monk (2 shared papers)Mikhail V. Keniya (2 shared papers)Mona Dawood (6 shared papers)Richard D. Cannon (1 shared paper)Onat Kadioglu (3 shared papers)
In The Last Decade
Edmond Fleischer
24 papers receiving 363 citations
Peers
Comparison fields: 5 of 68
- Toxicology 22
- Oncology 92
- Infectious Diseases 57
- Molecular Biology 180
- Applied Microbiology and Biotechnology 4
Countries citing papers authored by Edmond Fleischer
This map shows the geographic impact of Edmond Fleischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edmond Fleischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edmond Fleischer more than expected).
Fields of papers citing papers by Edmond Fleischer
This network shows the impact of papers produced by Edmond Fleischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edmond Fleischer. The network helps show where Edmond Fleischer may publish in the future.
Co-authors
The 25 scholars most cited alongside Edmond Fleischer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 51 | |
| 2 | 2020 | 43 | |
| 3 | 2019 | 31 | |
| 4 | 2017 | 25 | |
| 5 | 2020 | 20 | |
| 6 | 2019 | 19 | |
| 7 | 2019 | 17 | |
| 8 | 2021 | 15 | |
| 9 | 2022 | 15 | |
| 10 | 2020 | 14 | |
| 11 | 2021 | 13 | |
| 12 | 2019 | 13 | |
| 13 | 2020 | 13 | |
| 14 | 2019 | 10 | |
| 15 | 2022 | 10 | |
| 16 | 2022 | 9 | |
| 17 | 2020 | 9 | |
| 18 | 2024 | 8 | |
| 19 | 2020 | 8 | |
| 20 | 2021 | 7 |
About Edmond Fleischer
Edmond Fleischer is a scholar working on Molecular Biology, Oncology, Pharmacology, Hematology and Cell Biology, having authored 24 papers that have together received 366 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Microtubule and mitosis dynamics (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Cancer therapeutics and mechanisms (3 papers), Multiple Myeloma Research and Treatments (3 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Protein Degradation and Inhibitors (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Toxicology (22 citations), Oncology (92 citations), Infectious Diseases (57 citations), Molecular Biology (180 citations) and Applied Microbiology and Biotechnology (4 citations). Edmond Fleischer has collaborated with scholars based in Germany, China and Sudan. Frequent co-authors include Anette Klinger, Thomas Efferth, Sara Abdelfatah, Brian C. Monk, Mikhail V. Keniya, Mona Dawood, Richard D. Cannon, Onat Kadioglu, Letian Shan and Sami Hamdoun. Their work appears in journals such as Investigational New Drugs, Biochemical Pharmacology, Phytomedicine, Chemico-Biological Interactions and Pharmacological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.